ANTICHOLIUM
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- ANTICHOLIUM
- Generic name
- PHYSOSTIGMINE SALICYLATE
- Manufacturer
- Provepharm Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- b90b50e8-c8f1-4f2d-be6e-4d269b8c362c
- SPL ID
- 7c1db393-3664-425f-af20-8d2175fb634e
- Version
- 3
- Effective date
- 2025-11-11
- Source export date
- 2026-10-12
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:45:01
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | ANTICHOLIUM | openfda.brand_name | |
| generic name | PHYSOSTIGMINE SALICYLATE | openfda.generic_name | |
| manufacturer name | Provepharm Inc. | openfda.manufacturer_name | |
| ndc | package | 81284-831-05 | openfda.package_ndc |
| ndc | product | 81284-831 | openfda.product_ndc |
| ndc11 | package | 81284083105 | derived:openfda.package_ndc |
| rxcui | 2666374 | openfda.rxcui | |
| rxcui | 2666367 | openfda.rxcui | |
| spl id | 7c1db393-3664-425f-af20-8d2175fb634e | id | |
| spl set id | b90b50e8-c8f1-4f2d-be6e-4d269b8c362c | set_id | |
| unii | 2046ZRO9VU | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Precautions: Talk to your doctor before you are given ANTICHOLIUM ® if you suffer from diabetes mellitus, slowed heart rate (bradycardia), disturbances of the atrioventricular conduction system, Parkinson’s disease or ulcerative colitis. Hypersensitivity reactions may occur after administration of this medicine. These reactions may vary individually and may also cause life-threatening conditions. It is recommended to have emergency medication and medical aids ready. A risk/benefit analysis should be performed, and discontinuation of treatment should be considered. Acute cardiac arrest may be possible during treatment with tricyclic antidepressants; therefore, Anticholium should only be considered as an antidote for this indication while the patient has continuous ECG monitoring.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions: Like all medicines, ANTICHOLIUM ® can cause side effects, although not everybody gets them. System organ class Frequency: Unknown Immune system disorders Hypersensitivity reactions Endocrine disorders Hypersalivation Heart diseases Changes of the heart rate (both bradycardia and tachycardia), sinoatrial block Vascular diseases Low blood pressure (hypotension) Respiratory, thoracic and mediastinal disorders Spasms of the respiratory tract (broncho spasms) Gastrointestinal disorders Nausea, vomiting Skin and subcutaneous tissue disorders Sweating
adverse reactions table
<table width="50%" cellspacing="2" cellpadding="2"><colgroup><col width="50%" align="left" valign="top"/><col width="50%" align="left" valign="top"/></colgroup><tbody><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph"><content styleCode="bold">System organ class</content></paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph"><content styleCode="bold">Frequency: Unknown</content></paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Immune system disorders</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Hypersensitivity reactions</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Endocrine disorders</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Hypersalivation</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Heart diseases</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Changes of the heart rate (both bradycardia and tachycardia), sinoatrial block</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Vascular diseases</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Low blood pressure (hypotension)</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Respiratory, thoracic and mediastinal disorders</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Spasms of the respiratory tract (broncho spasms)</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Gastrointestinal disorders</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Nausea, vomiting</paragraph></td></tr><tr><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Skin and subcutaneous tissue disorders</paragraph></td><td styleCode="Botrule Lrule Rrule Toprule" align="left" valign="top"><paragraph styleCode="First TableParagraph">Sweating</paragraph></td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.